Figure 1. Disposition of study participants, by group. Data are no

Slides:

Advertisements

Similar presentations

Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.

Advertisements

Figure 1 The spatial and temporal distribution of diarrhoea rates

Figure 1. Flow diagram of participants recruited into the study.

Figure 1. Scree plot for the exploratory factor analysis (EFA) of the Death Depression Scale (DDS). From: Development and psychometric evaluation of a.

Figure 1. Period–cohort diagram.

From: Political Leadership and Power Redistribution

Figure 1. Varicella-related outpatient visit rates by age group, MarketScan 2003–2012. Varicella was the primary diagnosis code for data shown. Annual.

Figure 1. Forest plot: overall estimate

Figure 2. Dose distribution function for thyroid cancer cases and for healthy members of the cohort for adults (18 y of age and older at the time of the.

Figure 1. Programme provisions, eligibility, evaluation period and geographical coverage of programme over time From: Impact evaluation of free delivery.

Figure 3. Average response time by signal-to-noise ratio (SNR), group, and condition. Error bars represent standard error. Response time was measured as.

Figure 1. Mean recalled time (days) since the start of the last quit attempt by use of stop-smoking medications (SSM) and Heaviness of Smoking Index (HSI)

Figure 1. Shiga toxin–producing Escherichia coli (STEC) isolates by method of initial detection and STEC serotype, Connecticut, 2000–2009. From: Ten-Year.

Figure 3. Examples of tweets classified as ridicule.

Figure 1. Conceptual framework.

Figure 1. Antibody responses against homologous 2013 H7 virus in H7N9-infected patients. A, Serum samples from H7N9-infected patients were collected at.

Figure 1. Standardized coefficients for the SEM group model for heterosexual males. Latent constructs are shown in ellipses, and observed variables are.

Figure 1. Logos appearing in the choice experiment

Figure 1. Selection of papers.

Fig. 1 Flow chart of study selection

Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.

Figure 1. Orthodontic set-up and location of LLLT or placebo-laser

Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.

Fig. 2. Frequency of participants with a specific number of abnormal WCST T-scores at each cut-off. Performance of Non-neurological Older Adults on the.

From: Unmasking Masks in Makkah: Preventing Influenza at Hajj

Figure 1. Hepatitis B surface antigen (HBsAg) testing uptake and results among women delivering at Bairo Pite Clinic in Dili, Timor-Leste. From: Prevalence.

Figure 1. Paradigm for evaluation of those with latent tuberculosis infection (LTBI) based on risk of infection, risk of progression to tuberculosis, and.

Open Forum Infect Dis. 2014;1(suppl_1):S13-S14. doi: /ofid/ofu051.37

Figure 1. Prevalence of undocumented hepatitis C virus (HCV) infection, by age, race, and sex in 4713 emergency department patients, From: Evaluation.

Figure 4 Monthly all-cause (A-C) and pneumonia and influenza (P&I) mortality rates among Japanese children aged 5–9 years. Vertical dotted lines, January.

From: Where do we go from here

Figure 1. Overall survival of patients receiving alternative medicine (solid lines) vs conventional cancer treatment (dashed lines). Overall survival of.

Example 14. Schubert, Quartet in G Major, D

Figure 1. Relationship between Log Transfers and Age of Eldest HH Member(a) Bandwidth 0.05(b) Bandwidth 0.1(c) Bandwidth 0.5 From: The Effect of a Transfer.

From: Detection of Bacteriuria by Canine Olfaction

Figure 1. Single-Tree Model and BART Fits to Simulated Data.

Fig. 1 Selection of patients

Fig. 1 Flow diagram of patient selection and study design.

Figure 1 Effects of time constant and time-varying characteristics on occupational status at the start of a career and at the time of change in the time.

Figure 1 Flow of data processing

From: Estimating the Location of World Wheat Price Discovery

Figure 3. Hypothalamic–Pituitary–Adrenal (HPA)-axis functioning moderates crime exposure: regions of significance on X (crime). The lines represent two.

Figure 1. Time of initiation of therapeutic hypothermia according to who initiated it. Note the logarithmic scaling of the vertical axis. From: Initiation.

Figure 1 Percentage and number of arrivals with YFV check per entry location in Tanzania. Numbers in chart indicate number of arrivals per entry location.

NOTE.—Error bars in all figures represent standard errors of the means. From: So Close I Can Almost Sense It: The Interplay between Sensory Imagery and.

Figure 1. Percentage of trainees is represented on the y-axis for each competency/knowledge item represented in the x-axis. Only Poor/Fair (P/F) ratings.

Figure 1. Distribution of 25-hydroxyvitamin D (25(OH)D) levels at the baseline visit in a study population of adults aged 18–59 years (n = 309), Toronto,

Figure 1. Impact ratings for prospective memory lapses for younger (~age 30), middle-age (~age 50), and older (~age 65) adults. From: Daily Memory Lapses.

Figure 3. Biodistribution of Nickel was measured by using ICP-OES technique in (a) liver, (b) kidneys, (c) brain, (d) spleen, (e) heart, (f) blood, (g)

Figure 6. RRs for clinical cure rates stratified by different diseases

Figure 1. Flowchart of study participants

Figure 1. Percentage of participants in each group (holocaust survivors, prewar immigrants, and postwar immigrants) by the main coded strategies. From:

From: Herpes Zoster and Recurrent Herpes Zoster

Figure 5. Tungiasis: a 21-year-old woman returned from Peru with painful nodules on her toes. From: Illness in Travelers Returned From Brazil: The GeoSentinel.

Figure 2 Map of traveller arrivals to Tanzania and performed checks (arrivals with checks/all arrivals). Change: change of aircraft, no change: no change.

Figure 3. Changes from baseline in activated CD4+ T cells (% CD4+CD25+) during the 52-week intervention period in the.

Herpes zoster in non-hospitalized children

Figure 1. Overview of protein microarray titers for all hemagglutinin (HA) part antigens, by diet and species. Antigens ... Figure 1. Overview of protein.

Figure 1 Flow diagram detailing the systematic review process.

Figure 3. Acid-fast stain of the specimen showed acid-fast bacilli distributed in a perineural and periadnexal manner ... Figure 3. Acid-fast stain of.

Figure 1. Assembly of study cohort

Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.

Figure 1. CONSORT flow diagram

Figure 1. A, Provisional areas at risk for the establishment of Haemaphysalis longicornis in North America (red ... Figure 1. A, Provisional areas at risk.

Figure 1. Prevalence of parasitic infection and anemia among the children. Unless provided in the caption above, the following copyright applies to the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1. Rates of IEAT and AEAT in most common microorganisms causing inappropriate treatment. Abbreviations: AEAT, ... Figure 1. Rates of IEAT and AEAT.

Figure 1: Yearly net investment flows from Japan

Figure 1: Trade shares of South Korea's major trading partners (% of South Korea's total trade in goods) Figure 1: Trade shares of South Korea's major.

Figure 1. Kaplan Meier curves showing crude product limit survival estimates and 95% confidence intervals for time to ... Figure 1. Kaplan Meier curves.

Presentation transcript:

Figure 1. Disposition of study participants, by group. Data are no Figure 1. Disposition of study participants, by group. Data are no. (%) of participants. Group 1 comprised subjects aged ≥70 years who received zoster vaccine (ZV) ≥10 years previously, group 2 comprised subjects aged ≥70 years who never received ZV and were matched to group 1 subjects by 5-year age increments, group 3 comprised subjects aged ≥60 to <70 years who never received ZV, and group 4 comprised subjects aged ≥50 to <60 years who never received ZV. <sup>†</sup>ZV (ZOSTAVAX<sup>TM</sup>) received ≥10 years previously. From: Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults J Infect Dis. 2015;213(1):14-22. doi:10.1093/infdis/jiv480 J Infect Dis | © The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com. 1